Denosumab biosimilar by Sandoz Group for Humoral Hypercalcemia of Malignancy: Likelihood of Approval

Denosumab biosimilar is under clinical development by Sandoz Group and currently in Pre-Registration for Humoral Hypercalcemia of Malignancy.

Cook Medical sells ear, nose and throat devices to C2Dx

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Cook Medical has sold a

January 26, 2024

AI threatens to cement racial bias in clinical algorithms. Could it also chart a path forward?

This is Part 7 of Embedded Bias, a series revealing how race-based clinical algorithms pervade medicine and why it’s so difficult to change them. PROVIDENCE,

September 11, 2024

Red Meat-CVD Link Questioned; Drone AEDs to Bystanders; OCT-FFR in One Step?

A Mendelian randomization study challenged the notion that red and processed meats can cause cardiovascular disease and type 2 diabetes. (European Journal of Preventive Cardiology)

March 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.